Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.40M
2: EX-21.1 Subsidiaries List HTML 37K
3: EX-23.1 Consent of Experts or Counsel HTML 39K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 42K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 42K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 38K
73: R1 Document and Entity Information HTML 65K
57: R2 Consolidated Balance Sheets HTML 138K
69: R3 Consolidated Balance Sheets (Parenthetical) HTML 50K
78: R4 Consolidated Statements of Operations and HTML 196K
Comprehensive Income (Loss)
101: R5 Consolidated Statements of Changes in HTML 96K
Shareholders' Equity
59: R6 Consolidated Statements of Changes in HTML 38K
Shareholders' Equity (Parenthetical)
68: R7 Consolidated Statements of Cash Flows HTML 171K
51: R8 Summary of significant accounting policies HTML 151K
41: R9 Inventories HTML 66K
103: R10 Property, plant and equipment HTML 67K
80: R11 Patents and other intangible assets HTML 80K
79: R12 Goodwill HTML 112K
86: R13 Other current liabilities HTML 58K
87: R14 Long-term debt HTML 55K
84: R15 Shareholder's equity HTML 44K
88: R16 Derivative instruments HTML 82K
70: R17 Fair value measurements HTML 180K
74: R18 Commitments HTML 56K
82: R19 Business segment information HTML 274K
111: R20 Income taxes HTML 337K
96: R21 Sale of Breg and Disposition of Sports Medicine HTML 69K
Business
64: R22 Contingencies HTML 77K
81: R23 Pensions and deferred compensation HTML 43K
66: R24 Share-based compensation plans HTML 291K
32: R25 Earnings per share HTML 65K
97: R26 Quarterly financial data (Unaudited) HTML 366K
107: R27 Subsequent Events HTML 53K
46: R28 Schedule 1-Condensed Financial Information of HTML 234K
Registrant Orthofix International N.V.
45: R29 Schedule 2-Valuation and Qualifying Accounts HTML 119K
49: R30 Summary of significant accounting policies HTML 221K
(Policies)
50: R31 Summary of significant accounting policies HTML 84K
(Tables)
52: R32 Inventories (Tables) HTML 63K
21: R33 Property, plant and equipment (Tables) HTML 63K
94: R34 Patents and other intangible assets (Tables) HTML 77K
62: R35 Goodwill (Tables) HTML 113K
65: R36 Other current liabilities (Tables) HTML 57K
36: R37 Derivative instruments (Tables) HTML 74K
110: R38 Fair value measurements (Tables) HTML 168K
13: R39 Commitments (Tables) HTML 51K
54: R40 Business segment information (Tables) HTML 269K
100: R41 Income taxes (Tables) HTML 338K
34: R42 Sale of Breg and Disposition of Sports Medicine HTML 61K
Business (Tables)
44: R43 Share-based compensation plans (Tables) HTML 262K
48: R44 Earnings per share (Tables) HTML 62K
58: R45 Quarterly financial data (Unaudited) (Tables) HTML 366K
20: R46 Summary of Significant Accounting Policies - HTML 106K
Additional Information (Detail)
40: R47 Summary of Significant Accounting Policies - HTML 43K
Schedule of Useful Lives (Detail)
15: R48 Summary of Significant Accounting Policies - HTML 70K
Schedule of Components of Changes in Accumulated
Other Comprehensive Income (Loss) (Detail)
99: R49 Summary of Significant Accounting Policies - HTML 46K
Schedule of Components of Changes in Accumulated
Other Comprehensive Income (Loss) (Parenthetical)
(Detail)
33: R50 Inventories - Schedule of Inventories (Detail) HTML 55K
95: R51 Property, Plant and Equipment - Schedule of HTML 53K
Property,Plant and Equipment (Detail)
37: R52 Property, Plant and Equipment - Additional HTML 43K
Information (Detail)
55: R53 Patents and Other Intangible Assets - Schedule of HTML 54K
Patents and Other Intangibles Assets (Detail)
14: R54 Patents and Other Intangible Assets - Additional HTML 55K
Information (Detail)
18: R55 Goodwill - Schedule of Changes in Net Carrying HTML 75K
Amount of Goodwill (Detail)
47: R56 Other Current Liabilities - Summary of Other HTML 50K
Current Liabilities (Detail)
25: R57 Long-Term Debt - Additional Information (Detail) HTML 111K
104: R58 Derivative Instruments - Schedule of Fair Values HTML 44K
of Derivative Instruments (Detail)
61: R59 Derivative Instruments - Schedule of Gain (Loss) HTML 49K
Recognized on Derivative Instruments (Detail)
85: R60 Derivative Instruments - Additional Information HTML 60K
(Detail)
39: R61 Fair Value Measurements - Schedule of Financial HTML 72K
Assets and Liabilities Recorded at Fair Value on
Recurring Basis (Detail)
42: R62 Commitments - Additional Information (Detail) HTML 42K
92: R63 Commitments - Schedule of Future Minimum Lease HTML 50K
Payments Under Operating Leases, Net of Amount to
be Received Under Sub Leases (Detail)
89: R64 Business Segment Information - Additional HTML 35K
Information (Detail)
63: R65 Business Segment Information - Schedule of Net HTML 67K
Sales by SBU Reporting Segment (Detail)
91: R66 Business Segment Information - Summary of Net HTML 105K
Margin, Defined as Gross Profit Less Sales and
Marketing Expenses from Continuing Operations by
SBU Reporting Segment (Detail)
38: R67 Business Segment Information - Schedule of HTML 54K
Depreciation and Amortization by SBU Reporting
Segment (Detail)
67: R68 Business Segment Information - Summary of Net HTML 60K
Sales by Geographic Destination (Detail)
106: R69 Business Segment Information - Summary of HTML 52K
Property, Plant and Equipment of Reporting
Segments by Geographic Area (Detail)
17: R70 Income Taxes - Schedule of Income from Continuing HTML 44K
Operations Before Provision for Income Taxes
(Detail)
31: R71 Income Taxes - Schedule of Provision for (Benefit HTML 64K
from) Income Taxes on Continuing Operations
(Detail)
56: R72 Income Taxes - Schedule of Tax Effects of HTML 95K
Significant Temporary Differences Comprising
Deferred Tax Assets and Liabilities (Detail)
23: R73 Income Taxes - Additional Information (Detail) HTML 76K
109: R74 Income Taxes - Schedule of Effective Income Tax HTML 119K
Rate Reconciliation for Continuing Operations
(Detail)
35: R75 Income Taxes - Schedule of Gross Unrecognized Tax HTML 49K
Benefits (Excluding Interest and Penalties)
(Detail)
26: R76 Sale of Breg and Disposition of Sports Medicine HTML 64K
Business - Additional Information (Detail)
30: R77 Sale of Breg and Disposition of Sports Medicine HTML 71K
Business - Schedule of Information Related to Sale
of Breg (Detail)
19: R78 Contingencies - Additional Information (Detail) HTML 73K
22: R79 Pensions and Deferred Compensation - Additional HTML 81K
Information (Detail)
76: R80 Share-based Compensation plans - Additional HTML 133K
Information (Detail)
28: R81 Share-based Compensation Plans - Schedule of HTML 62K
Share-Based Compensation by Line Item in
Consolidated Statements of Operations (Detail)
105: R82 Share-based Compensation Plans - Schedule of HTML 59K
Share-based Payment Award, Valuation Assumptions
(Detail)
53: R83 Share-based Compensation Plans - Schedule of Stock HTML 79K
Option Activity (Detail)
83: R84 Share-based Compensation Plans - Schedule of Stock HTML 147K
Options Outstanding and Exercisable by Price Range
(Detail)
90: R85 Share-based Compensation Plans - Schedule of HTML 60K
Changes in Restricted Stock (Detail)
27: R86 Earnings Per Share - Schedule of Reconciliation of HTML 46K
Weighted Average Shares Used in Calculation of
Basic and Diluted Earnings Per Share (Detail)
29: R87 Earnings Per Share - Additional Information HTML 45K
(Detail)
102: R88 Quarterly Financial Data - Condensed Consolidated HTML 103K
Statement of Operations (Detail)
24: R89 Quarterly Financial Data - Condensed Consolidated HTML 54K
Balance Sheets (Detail)
77: R90 Subsequent Events - Additional Information HTML 57K
(Detail)
72: R91 Schedule 1- Condensed Financial Information of HTML 111K
Registrant Orthofix International N.V. - Condensed
Balance Sheets (Unaudited) (Detail)
93: R92 Schedule 1 - Condensed Financial Information of HTML 70K
Registrant Orthofix International NV - Condensed
Statements of Operations (Unaudited) (Detail)
71: R93 Schedule 1 - Condensed Financial Information of HTML 101K
Registrant Orthofix International NV - Condensed
Statement of Cash Flows (Unaudited) (Detail)
60: R94 Schedule 1 - Condensed Financial Information of HTML 47K
Registrant Orthofix International NV - Additional
information (Detail)
98: R95 Schedule 2 - Valuation and Qualifying Accounts HTML 60K
(Detail)
108: XML IDEA XML File -- Filing Summary XML 193K
16: EXCEL IDEA Workbook of Financial Reports XLSX 273K
43: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 4.26M
7: EX-101.INS XBRL Instance -- ofix-20141231 XML 5.26M
9: EX-101.CAL XBRL Calculations -- ofix-20141231_cal XML 305K
10: EX-101.DEF XBRL Definitions -- ofix-20141231_def XML 753K
11: EX-101.LAB XBRL Labels -- ofix-20141231_lab XML 1.72M
12: EX-101.PRE XBRL Presentations -- ofix-20141231_pre XML 1.34M
8: EX-101.SCH XBRL Schema -- ofix-20141231 XSD 265K
75: ZIP XBRL Zipped Folder -- 0001564590-15-003012-xbrl Zip 273K
Filing Submission 0001564590-15-003012 – SGML Text
To view the SGML, please refresh this page.
↑Top
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Sun., May 5, 8:12:44.2am ET 
